• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Castlight Health Inc. (Amendment)

    1/24/22 4:26:14 PM ET
    $CSLT
    Managed Health Care
    Health Care
    Get the next $CSLT alert in real time by email
    SC 13G/A 1 castlight_13ga3.htm SC 13G/A
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G
     
    Under the Securities Exchange Act of 1934
     
    (Amendment No. 3)*
     
    Castlight Health, Inc.
    (Name of Issuer)
     
    Class B Common Stock, par value $0.0001 per share
    (Title of Class of Securities)
     
    14862Q100
    (CUSIP Number)
     
    December 31, 2021
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    o Rule 13d-1(b)
    x Rule 13d-1(c)
    o Rule 13d-1(d)
       

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).  

     
     
    CUSIP No. 14862Q100 13G Page 2 of 8

     

                 
    1.

    Names Of Reporting Persons

    I.R.S. Identification No. Of Above Persons (Entities Only)

     

    GAGNON SECURITIES LLC

     

     
           
    2. check the appropriate box if a group (a) o
    (b) x

    3. sec use only    
           
    4.

    citizenship or place of organization

     

    DELAWARE LIMITED LIABILITY COMPANY

     

       
    number of
    shares
    beneficially
    owned by
    each
    reporting
    person with:
    5. sole voting power     0
    6. shared voting power     1,216,467
    7. sole dispositive power     0
    8. shared dispositive power     1,289,332
    9. aggregate amount beneficially owned by each reporting person   1,289,332
    10. check box if the aggregate amount in row (9) excludes certain shares (See Instructions) o
    11. percent of class represented by amount in row (9)  

    1.0%

    12. type of reporting person (See Instructions)     IA, BD

     

     
     
     
    CUSIP No. 14862Q100 13G Page 3 of 8

     

                 
    1.

    Names Of Reporting Persons

     

    GAGNON ADVISORS, LLC

     

     
           
    2. check the appropriate box if a group (a) o
    (b) x

    3. sec use only    
           
    4.

    citizenship or place of organization

     

    DELAWARE LIMITED LIABILITY COMPANY

     

       
    number of
    shares
    beneficially
    owned by
    each
    reporting
    person with:
    5. sole voting power     0
    6. shared voting power     2,227,422
    7. sole dispositive power     0
    8. shared dispositive power    

    2,227,422

    9. aggregate amount beneficially owned by each reporting person  

    2,227,422

    10. check box if the aggregate amount in row (9) excludes certain shares (See Instructions) o
    11. percent of class represented by amount in row (9)  

    1.6%

    12. type of reporting person (See Instructions)     IA

     

     
     
     
    CUSIP No. 14862Q100 13G Page 4 of 8

     

                 
    1.

    Names Of Reporting Person
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

     

    NEIL GAGNON

     

     
           
    2. check the appropriate box if a group (a) o
    (b) x

    3. sec use only    
           
    4.

    citizenship or place of organization

     

    USA

     

       
    number of
    shares
    beneficially
    owned by
    each
    reporting
    person with:
    5. sole voting power    

    537,544

    6. shared voting power    

    3,907,011

    7. sole dispositive power    

    537,544

    8. shared dispositive power    

    4,035,070

    9. aggregate amount beneficially owned by each reporting person  

    4,572,614

    10. check box if the aggregate amount in row (9) excludes certain shares (See Instructions) o
    11. percent of class represented by amount in row (9)  

    3.4%

    12. type of reporting person (See Instructions)     IN

     

     
     
     
    CUSIP No. 14862Q100 13G Page 5 of 8
    Item 1.  

     

    (a) Name of Issuer: Castlight Health, Inc.
         
    (b) Address of Issuer’s Principal

    150 Spear Street, Suite 400

      Executive Offices:

    San Francisco, CA 94105

     

    Item 2.

    (a) Name of Person Filing:

    As of the date hereof, Neil Gagnon has sole voting and dispositive power over 537,544 shares of the Issuer’s Class B Common Stock, par value $0.0001 per share (the “common stock”). In addition, Mr. Gagnon has shared voting power over 3,907,011 shares of common stock and shared dispositive power over 4,035,070 shares of common stock.

     

    Mr. Gagnon is the managing member and principal owner of Gagnon Securities LLC (“GS”), an investment adviser registered with the U.S. Securities and Exchange Commission (“SEC”) under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), and a registered broker-dealer, in its role as investment manager to several customer accounts, foundations, partnerships and trusts (collectively, the “Accounts”) to which it furnishes investment advice. As of the date hereof, GS and Mr. Gagnon may be deemed to share voting power with respect to 1,216,467 shares of common stock held in the Accounts and dispositive power with respect to 1,289,332 shares of common stock held in the Accounts. GS and Mr. Gagnon expressly disclaim beneficial ownership of all securities held in the Accounts.

     

    Mr. Gagnon is also the Chief Executive Officer of Gagnon Advisors, LLC (“Gagnon Advisors”), an investment adviser registered with the SEC under the Advisers Act. As of the date hereof, Mr. Gagnon and Gagnon Advisors, in its role as investment manager to Gagnon Investment Associates, LLC (“GIA”), a private investment fund, may be deemed to share voting and dispositive power with respect to the 2,227,422 shares of common stock held by GIA. Gagnon Advisors and Mr. Gagnon expressly disclaim beneficial ownership of all securities held by GIA.

     

    (b) Address of Principal Business Office 1370 Ave. of the Americas, 24th Floor
      or, if none, Residence: New York, NY 10019

     

    (c) Citizenship:

    Gagnon Securities LLC

    Delaware limited liability company

       

    Gagnon Advisors, LLC

    Delaware limited liability company

       

    Neil Gagnon

    USA

         
    (d) Title of Class of Securities:

    Class B Common Stock, par value $0.0001 per share

         
    (e) CUSIP Number: 14862Q100

     

     
     
     
    CUSIP No. 14862Q100 13G Page 6 of 8
       
    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

     

    (a)  o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
         
    (b)  o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
         
    (c)  o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
         
    (d)  o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
         
    (e)  o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
         
    (f)  o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
         
    (g)  o A parent holding company or control person in accordance with § 13d-1(b)(1)(ii)(G);
         
    (h)  o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
         
    (i)  o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15U.S.C. 80a-3);
         
    (j)  o A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
         
    (k)  o Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

     

     
     
     
    CUSIP No. 14862Q100 13G Page 7 of 8
    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. All information in this Item 4 is as of December 31, 2021.

     

      (a) Amount beneficially owned:

    Gagnon Securities LLC

    4,389,568

         

    Gagnon Advisors, LLC

    2,958,279

         

    Neil Gagnon

    8,403,707

           
      (b) Percent of class:

    Gagnon Securities LLC

    3.3%

         

    Gagnon Advisors, LLC

    2.2%

         

    Neil Gagnon

    6.3%

           
         

    Calculation of percentage of beneficial ownership is based on 133,733,905 shares of the Issuer’s common stock outstanding as of October 31, 2021, as reported on the Issuer’s Form 10-Q filed on November 3, 2021.

           
      (c) Number of shares as to which the person has:

     

      (i) Sole power to vote or to direct the vote:

    Gagnon Securities LLC

    0

         

    Gagnon Advisors, LLC

    0
         

    Neil Gagnon

    537,544

           
      (ii) Shared power to vote or to direct the vote:

    Gagnon Securities LLC

    3,733,718

         

    Gagnon Advisors, LLC

    2,958,279

         

    Neil Gagnon

    7,738,104

           
      (iii) Sole power to dispose or to direct the disposition of:

    Gagnon Securities LLC

    0
         

    Gagnon Advisors, LLC

    0
         

    Neil Gagnon

    537,544

           
      (iv) Shared power to dispose or to direct the disposition of:

    Gagnon Securities LLC

    4,389,568

         

    Gagnon Advisors, LLC

    2,958,279

         

    Neil Gagnon

    7,866,163

    Item 5. Ownership of Five Percent or Less of a Class.
       

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    The Accounts described above in Item 2 have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities held in their respective accounts. To the knowledge of the Reporting Person, the interest in any such account does not exceed 5% of the class of securities. Except to the extent described herein, the Reporting Person disclaims beneficial ownership of all such securities.

     

    Items 7 – 9. Not Applicable.

     

     
     
     
    CUSIP No. 14862Q100 13G Page 8 of 8
       
    Item 10. Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Section 230.14a-11.

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: January 24, 2022

       
      NEIL GAGNON
       
     

    /s/ Neil Gagnon

       
     

    GAGNON SECURITIES LLC

       
     

    /s/ Neil Gagnon

      Name:  Neil Gagnon 
     

    Title:    Managing Member

       
     

    GAGNON ADVISORS, LLC

       
     

    /s/ Neil Gagnon

      Name:  Neil Gagnon 
     

    Title:    Chief Executive Officer

       
     
     
    Get the next $CSLT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CSLT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CSLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Verhave Judith K. returned 351,516 units of Class B Common Stock to the company, closing all direct ownership in the company

    4 - CASTLIGHT HEALTH, INC. (0001433714) (Issuer)

    2/18/22 2:18:36 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form 4: Van Zant Kenny returned 661,794 units of Class B Common Stock to the company, closing all direct ownership in the company

    4 - CASTLIGHT HEALTH, INC. (0001433714) (Issuer)

    2/18/22 2:17:39 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form 4: Roberts Bryan E returned 5,660,448 units of Class B Common Stock to the company

    4 - CASTLIGHT HEALTH, INC. (0001433714) (Issuer)

    2/18/22 2:13:57 PM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    SEC Filings

    View All

    SEC Form 15-12B filed by Castlight Health Inc.

    15-12B - CASTLIGHT HEALTH, INC. (0001433714) (Filer)

    2/28/22 2:02:35 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form 25-NSE filed by Castlight Health Inc.

    25-NSE - CASTLIGHT HEALTH, INC. (0001433714) (Subject)

    2/17/22 3:30:16 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form S-8 POS filed by Castlight Health Inc.

    S-8 POS - CASTLIGHT HEALTH, INC. (0001433714) (Filer)

    2/17/22 8:55:41 AM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Castlight Health, Now Part of apree health, Adds Six Digital Health Partners and New Pharmacy Savings Category to its Ecosystem

    New additions bolster the already robust platform, making it even easier for members to identify and access programs best suited to their top health needs SAN FRANCISCO, Sept. 20, 2022 /PRNewswire/ -- Castlight Health, the leading health navigation platform of apree health, today announced six additions to its industry-leading ecosystem, the strongest and most comprehensive with more than 30 fully integrated partners that can be purchased through Castlight, across 20 categories, and the ability to plug in any vendor. These additions—Brightline, Kindbody, RazorMetrics, Rx Savings Solutions, WithMe, and Wondr—include Castlight's first pediatric-focused mental health solution and the launch of

    9/20/22 11:30:00 AM ET
    $CSLT
    Managed Health Care
    Health Care

    Castlight Health Selected to Enable New Capabilities for Blue Cross and Blue Shield of Minnesota

    Castlight's technology and data to power modernized navigation and advocacy solution for health plan members SAN FRANCISCO, June 15, 2022 /PRNewswire/ -- Castlight Health, a leader in connected health navigation, today announced a collaboration with Blue Cross and Blue Shield of Minnesota (Blue Cross) to launch a new health, wellness, and care navigation solution for commercial health plan members, beginning January 1, 2023. The new solution uses Castlight's powerful navigation technology to reduce the overall complexity of healthcare and drive Blue Cross members to more perso

    6/15/22 9:00:00 AM ET
    $CSLT
    Managed Health Care
    Health Care

    Castlight's Workforce Health Index Details the Adverse Health Effects of Delayed Care Due to COVID-19

    Report finds preventive care spending continues to lag but musculoskeletal and behavioral health spending steeply rising SAN FRANCISCO, April 5, 2022 /PRNewswire/ -- Castlight Health, Inc., a leader in connected navigation, today released a new Workforce Health Index, revealing how the COVID-19 pandemic has impacted the way commercially-insured populations across the U.S. utilize their healthcare and wellbeing benefits. The annual Workforce Health Index provides detail on medical spending and benefits utilization from 2018 through 2021 and projected spending for 2022, as well as a state-by-state dataset demonstrating regional variation in medical spending over this five-year period.

    4/5/22 9:00:00 AM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity reiterated coverage on Castlight Health with a new price target

    Canaccord Genuity reiterated coverage of Castlight Health with a rating of Hold and set a new price target of $2.00 from $1.00 previously

    2/11/21 11:30:07 AM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    Financials

    Live finance-specific insights

    View All

    Castlight Health Announces Third Quarter 2021 Results

    SAN FRANCISCO, Nov. 2, 2021 /PRNewswire/ -- Castlight Health, Inc. (NYSE:CSLT), a leading health navigation platform provider, today announced results for its third quarter ended September 30, 2021. "We delivered a solid third quarter reflecting continued progress across both our employer and health plan businesses," said Maeve O'Meara, chief executive officer of Castlight Health. "This quarter our team produced our highest direct-to-employer bookings in over three years, which led to our third straight quarter of sequential ARR growth, and our health plan pipeline grew substa

    11/2/21 4:05:00 PM ET
    $CSLT
    Managed Health Care
    Health Care

    Castlight Health to Announce Third Quarter 2021 Results

    SAN FRANCISCO, Oct. 19, 2021 /PRNewswire/ -- Castlight Health, Inc. (NYSE:CSLT), a leader in healthcare navigation, will release its third quarter 2021 financial results on Tuesday, November 2, 2021, after the market close. At 5:00 p.m. Eastern Time, senior management will host a conference call to review the company's financial performance. The live conference call will be available at (833) 238-7953. Please dial in at least five minutes before the scheduled start time to register. The call replay will be available for one week, starting at 8:00 p.m. ET on November 2, 2021

    10/19/21 8:30:00 AM ET
    $CSLT
    Managed Health Care
    Health Care

    Castlight Health Announces Second Quarter 2021 Results

    SAN FRANCISCO, Aug. 3, 2021 /PRNewswire/ -- Castlight Health, Inc. (NYSE:CSLT), a leading health navigation platform provider, today announced results for its second quarter ended June 30, 2021. "We had a strong second quarter, achieving the top-end of our revenue guidance and generating our fifth straight quarter of non-GAAP profitability and positive cash flow," said Maeve O'Meara, chief executive officer of Castlight Health. "We were pleased with pipeline progress, as our late-stage pipeline for the quarter is the largest in four years, we reported a second low churn quarte

    8/3/21 4:05:00 PM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Castlight Health Inc. (Amendment)

    SC 13G/A - CASTLIGHT HEALTH, INC. (0001433714) (Subject)

    2/14/22 3:29:59 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form SC 13G/A filed by Castlight Health Inc. (Amendment)

    SC 13G/A - CASTLIGHT HEALTH, INC. (0001433714) (Subject)

    2/9/22 9:07:15 AM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form SC 13G filed by Castlight Health Inc.

    SC 13G - CASTLIGHT HEALTH, INC. (0001433714) (Subject)

    2/4/22 4:12:10 PM ET
    $CSLT
    Managed Health Care
    Health Care